Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Women 18 years or older~2. Neoadjuvant chemotherapy planned prior to surgical excision~3. Scheduled for target axillary lymph node dissection including the localized lymph node and sentinel lymph node~Exclusion Criteria:~1. Pregnant or nursing women~2. Allergy to lidocaine or gadolinium~3. Contraindication to MRI (i.e. pacemaker)~4. Axillary Infection~5. Prior axillary radiation~6. Known allergy to bone wax, beeswax or propolis

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Axillary Magseed (Type: EXPERIMENTAL): Single cohort of twenty women receiving neoadjuvant chemotherapy with breast cancer will have a Magseed inserted into a biopsy proven metastatic axillary lymph node for pre-surgical localization.

Based on this trial design, predict the completion outcome and termination type (if applicable).